Atlas Trials

Role of Microglial Activation and Norepinephrine Transporter Abnormalities in Pathogenesis of MS-related Fatigue

Clinical trial NCT04144257 · COMPLETED

Trial details

NCT number
NCT04144257
Sponsor
Brigham and Women's Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2020-03-12
Primary completion
2021-04-13
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.